Nasus Pharma clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
FMXIN002 in Patients at Risk of AnaphylaxisNCT07045701Adrenalin 0.5mg Injectable Product, Epinephrine 4mg nasal powder sprayEnrolling by invitation2026-06-12Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.